C

CSL
CSL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$118.16B
EV
A$138.24B
Shares Outstanding
484.21M
Beta
0.33

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
A$200.43
P/E 2025E
23.97x
P/Revenue 2025E
4.82x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CSL Limited

gainify

C

CSL Limited

CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqi...

Sector

Healthcare

Industry

Biotechnology

CEO

McKenzie, Paul

Employees

32,698

IPO Date

1994-06-01

Headquarters

655 Elizabeth Street Melbourne, Victoria, 3000, Australia

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.